Group 1: Market Trends - The paper sector continues its upward trend, with Nine Dragons Paper (02689.HK) leading the gains, rising over 9% after announcing a price increase of 30 CNY/ton for corrugated paper and recycled cardboard starting August 1, reflecting an optimized supply-demand structure in the industry [1] - The brokerage sector saw collective strength, with major Chinese brokerages like Dongfang Securities (03958.HK) and Zhongyuan Securities (01375.HK) rising over 6% and 5% respectively, indicating significant capital inflow into the sector [1] - Urban Beauty (02298.HK) surged 13% as its online GMV for 2024 is projected to reach 1.57 billion CNY, marking a 100% year-on-year increase, showcasing the effectiveness of its new retail transformation [1] Group 2: Company Performance - China Duty Free Group (01880.HK) soared 17% after Macquarie's report indicated a narrowing year-on-year revenue decline from 19.5% in Q4 2024 to 11% in Q1 2025, with a stable gross margin of 33% [1] - The gaming sector experienced a broad increase, with companies like 澳博控股 (00880.HK) and 银河娱乐 (00027.HK) rising over 3%, supported by UBS data showing Macau's average daily gaming revenue in July at 683 million MOP, a 14% year-on-year increase [2] - 雍禾医疗 (02279.HK) saw a 13% increase after forming a strategic partnership with Meituan Health to build a medical-grade hair health service system [2] Group 3: Real Estate and Financing - The Hong Kong real estate sector collectively strengthened, with Country Garden (02007.HK) leading with nearly a 10% rise, driven by improved financing conditions as indicated by the People's Bank of China's report showing a recovery in real estate loan growth [3] - Meilan Airport (0357.HK) rose 10% as CITIC Securities highlighted the significance of Hainan's trade opening, which is expected to benefit the local tourism industry [3] Group 4: Gold Sector Decline - The gold sector faced pressure, with companies like 潼关黄金 (00340.HK) and 大唐黄金 (08331.HK) dropping over 4%, attributed to a decline in spot gold prices below 3,380 USD/oz, driven by reduced safe-haven appeal due to easing trade tensions [4] Group 5: US Market Highlights - Futu Holdings (FUTU.US) rose 2.82% after announcing a long-term strategic partnership with Huaxia Fund to promote the integration of traditional finance and blockchain technology [5] - Japanese automotive stocks surged, with Toyota (TM.US) and Honda (HMC.US) rising over 13% following news of a trade agreement reducing tariffs on Japanese cars [6] - Nuclear power stocks in the US saw significant gains, with Oklo Inc (OKLO.US) rising 9.21%, reflecting a growing interest in nuclear energy [5]

2025年7月11日，中国非公立医疗机构协会毛发医学专业委员会（以下简称"毛发医学专委会"）筹建工 作座谈会在北京雍禾医院正式召开，标志着中国毛发医疗行业正式迈入标准体系建设的关键阶段。 毛发医学专委会是中国非公立医疗机构协会分支机构之一，雍禾医疗作为该专委会主要发起单位之一， 承办本次筹建工作座谈。来自全国的医疗、药企、科研、高校等领域的专家代表共聚一堂，围绕行业规 范建设、人才培养、技术协同与学术发展展开深入探讨。 立标先行，雍禾推动毛发医疗高质量发展 在毛发健康成为国民健康焦点的当下，中国毛发医疗行业正迎来前所未有的高速增长期。根据 Frost&Sullivan的测算，2030年我国毛发医疗服务市场将达到1381亿元，未来十年复合年增长率将达 22.3%。 但在快速膨胀的需求面前，行业人才、技术、标准体系等关键支撑仍存在明显缺口。 毛发医学专委会筹建工作座谈会伊始，中国非公立医疗机构协会常务副会长兼秘书长郝德明发表讲话。 目前，雍禾已在北京、上海等地建立综合毛发医院，设立脱发科、女性科、复查科等多个专科科室，涵 盖诊断、治疗、术后管理的一体化服务体系；在人才体系建设上，雍禾提出医生分级体系，强调医术与 ...

Group 1 - The core event was the "2025 High-Quality Consumer Brand TOP 100 Innovation Ecosystem Conference" held in Shanghai, where Yonghe Medical was recognized as one of the "Top Ten Consumer Technology Innovation Brands" for its continuous investment and innovation in AI service systems and digital transformation in hair health [1][3]. - The award was initiated by Southern Metropolis Daily in collaboration with multiple organizations, focusing on five dimensions: brand influence, innovation, social responsibility, enterprise scale, and market potential, to identify innovative forces driving consumption upgrades [3]. - AI application upgrades emerged as a key theme at the conference, with various brands from sectors such as beauty, healthcare, home, apparel, and retail showcasing their collective innovations in smart manufacturing and user operations [3]. Group 2 - Yonghe Medical is leveraging AI technology to reconstruct service models and enhance user experience in the hair health sector, becoming one of the most digitized companies in this field [3][4]. - The company has developed an "AI Hair Health Self-Test Mini Program" that uses image recognition and hair loss assessment models to provide users with personalized treatment suggestions based on uploaded photos [3][4]. - Yonghe Medical is also advancing "hair loss gene testing" in collaboration with Sun Yat-sen University to create predictive models for individual risk assessment and personalized prevention strategies [4]. Group 3 - Yonghe Medical has been in the hair medical field for nearly 20 years, offering a comprehensive range of services and has established a brand matrix that includes various specialized brands [4]. - According to the "2023 China Hair Health Lifestyle Blue Book," Yonghe Medical ranks first in market size, female selection rate, brand awareness, user satisfaction, and recommendation rate within the industry [6]. - The company plans to continue enhancing AI's role in hair health management and expand its smart products and services to create a user-centered one-stop hair health management service [7].

Company Overview - Yonghe Medical Group Limited is a medical group providing one-stop hair medical services, focusing on the hair medical service market since 2005 [3] - The company has established a brand matrix including "Yonghe Medical," "Yonghe Hair Transplant," "Shiyunxun," "Yonghe Fazhichu," and "Hafada" [3] - As of June 30, 2023, the company operates 72 hair transplant medical institutions across 68 cities in China [3] - The company has built a professional medical team of over 1,600 members, including more than 300 registered doctors and over 1,000 nurses [3] Financial Performance - For the fiscal year ending December 31, 2024, Yonghe Medical reported total revenue of 1.804 billion yuan, a year-on-year increase of 1.53% [2] - The company recorded a net profit attributable to shareholders of -226 million yuan, showing a significant year-on-year increase of 58.58% [2] - The gross profit margin stands at 60.08%, while the debt-to-asset ratio is 58.65% [2] Stock Performance - Over the past month, Yonghe Medical's stock has increased by 73.45%, and year-to-date, it has risen by 117.78%, outperforming the Hang Seng Index's increase of 19.1% [2] - As of the latest trading session, the stock price was 2.22 HKD per share, reflecting a 13.27% increase with a trading volume of 3.186 million shares and a turnover of 6.9939 million HKD [1] Industry Valuation - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -2.53 times, with a median of 0.38 times [3] - Yonghe Medical's P/E ratio is -4.21 times, ranking 89th in the industry [3] - Comparatively, other companies in the sector have P/E ratios such as Giant Star Medical Holdings at 0.28 times, Jingjiu Kangliao at 0.38 times, and others ranging up to 5.35 times [3]

Core Insights - The hair medical industry is experiencing innovation in service models driven by the diverse needs of young people for hair health management [1][2] - A partnership between Yonghe Medical Group and Meituan Health aims to provide a one-stop hair health management service through systematic collaboration [1][4] Group 1: Market Trends - Hair loss is increasingly becoming a significant issue for young people, with data indicating a trend towards younger demographics, particularly among those born in the 1990s and 2000s [2] - On the Meituan platform, users under 35 account for 55% of hair medical service users, with 23% of users aged 20-25 being hair transplant customers [2] Group 2: Consumer Behavior - Two notable consumer behavior trends are emerging: early intervention in treatment and a rising demand for aesthetic hair transplant services, with searches for "hairline" exceeding those for "hair transplant" by 16 percentage points [4] - In 2024, the number of transaction users for Yonghe Medical on the Meituan platform is expected to grow by over 20% year-on-year [4] Group 3: Service Innovations - Yonghe Medical and Meituan Health are focusing on enhancing online one-stop product service experiences and fulfillment guarantees to adapt to market changes [4] - The Yonghe hair transplant online store on the Meituan platform will evolve from a single service offering to a comprehensive product service covering the entire treatment cycle [4] - Meituan Health has seen a significant increase in users purchasing hair growth and strengthening products, indicating a growing demand for hair health management solutions [4]

报名：首届全球心血管大会 | 最新议程 合作伙伴征集：2025全球手术机器人大会 从以往不修边幅的 "糙汉" 形象，到如今追求美丽的 "精致大叔"， 男性对于医美的需求似乎已从曾经的小 众 "隐秘角落" 迈向社会主流视野 。从"护肤是娘炮"到"颜值即正义"，男性对美的追求不再遮遮掩掩，而 是更加自信地表达。 从性别比例来看，男性消费者在美容美体行业中的占比逐年提升。2023年，男性消费者数量相比2021年增 长了68%，相比2019年更是增加了227%。 尽管女性仍然是医美市场的主流，但男性的增速更快 ，不断上 涨的需求背后，不仅反映了社会对男性美的追求正在逐步改变，同时也预示着 医美行业的又一个细分市场 逐步崛起 。 # 探 索医美 " 男 半 球 " 或许一些读者曾见过这样的场景，在某家美容机构候诊区，几位男士安静地坐在沙发上等候，年龄从20出 头到40多岁不等，他们低头看手机，偶尔抬头瞥一眼墙上的时钟。 近年来，像这样的场景越来越常见—— 男性走进美容院，不再只是陪伴，而是成为主角 ，接受割双眼 皮、隆鼻、面部调整等医美项目。从"糙汉"到"精致"，男性对容貌的追求正悄然打破传统观念，成为一股 不可忽视的 ...

Group 1 - The core viewpoint of the news highlights the recent performance of Yonghe Medical, which saw a stock price increase of 9.38% on May 9, closing at 1.05 HKD per share, while the Hang Seng Index rose by 0.4% to 22867.74 points [1] - Over the past month, Yonghe Medical has experienced a cumulative increase of 1.05%, and a year-to-date increase of 6.67%, which is lower than the Hang Seng Index's increase of 13.54% [2] - Financial data shows that as of December 31, 2024, Yonghe Medical achieved total revenue of 1.804 billion RMB, a year-on-year increase of 1.53%, and a net profit attributable to shareholders of -226 million RMB, a year-on-year increase of 58.58%, with a gross margin of 60.08% and a debt-to-asset ratio of 58.65% [2] Group 2 - Currently, there are no institutional investment ratings for Yonghe Medical, and the average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.69 times, with a median of 0.28 times [3] - Yonghe Medical's P/E ratio stands at -2.06 times, ranking 90th in the industry, compared to other companies such as Giant Medical Holdings at 0.19 times and Jingjiu Health at 0.38 times [3] - Yonghe Medical Group Limited is a medical group providing one-stop hair medical services, focusing on the hair medical service market since 2005, and has established a brand matrix including "Yonghe Medical," "Yonghe Hair Transplant," and others, with 72 hair transplant medical institutions across 68 cities in China as of June 30, 2023 [3]

Core Viewpoint - Yonghe Medical (02279) reported a total revenue of 1.806 billion yuan for the fiscal year 2024, reflecting a year-on-year growth of 1.5%, while the net profit attributable to shareholders was a loss of 226 million yuan, an improvement from a loss of 546 million yuan in the previous year [3] Financial Performance - The company achieved a net cash flow from operating activities of 229 million yuan, compared to a negative 17.15 million yuan in the same period last year [3] - Basic earnings per share were reported at -0.45 yuan, with a weighted average return on equity of -26.99% [3][25] - As of April 29, the price-to-book ratio (TTM) was approximately 0.67 times, and the price-to-sales ratio (TTM) was about 0.26 times [3] Revenue Composition - In 2024, the revenue composition included 1.3307 billion yuan from hair transplant medical services and 445.8 million yuan from medical hair care services [20] - The company operates a full industry chain brand matrix centered around "Yonghe Medical," including specialized brands for hair transplant and medical hair care [13] Cash Flow and Financing - The net cash flow from financing activities was -291 million yuan, a decrease of 106 million yuan year-on-year, while the net cash flow from investment activities was -53.26 million yuan, compared to 246 million yuan in the previous year [29] Asset and Liability Changes - As of the end of 2024, the company's right-of-use assets decreased by 37.93%, while cash and cash equivalents decreased by 18.27% [37] - The company's lease liabilities decreased by 39.62%, and short-term borrowings decreased by 67.25% [40] - The current ratio was reported at 1.15, and the quick ratio was 1.08 [43]

Business Overview - Yonghe Medical Group is a leading medical group in China specializing in hair-related healthcare services, offering a one-stop service model that includes hair transplant and medical hair care[5]. - The company has successfully established Svenson Medical Hair Care Centers in China and expanded its footprint by acquiring the Hong Kong business of Nu/Hart Hair, enhancing its market presence[5][8]. - Yonghe Medical Group has built a standardized and scalable business model, achieving industry-leading operational capabilities that improve cost control and profitability[9]. - The company collaborates with Class IIIA hospitals and renowned academic institutions to enhance its research and development capabilities[9]. - Yonghe Medical Group is actively promoting the adoption of new technologies, including data analysis and online services, to improve patient care and drive business development[6][9]. - The establishment of a joint hair laboratory with Peking University People's Hospital aims to standardize diagnostic and treatment procedures for hair loss diseases, marking a significant advancement in the industry[5][8]. - The company believes that its pioneering actions will enhance core competitiveness and strengthen its leading position in the hair-related healthcare service industry[8]. - Yonghe Medical Group's focus on innovation and technology positions it for sustained growth in the future[6][9]. - The company has a strong commitment to improving operational efficiency and enhancing patient services through continuous technological advancements[6][9]. - Yonghe Medical Group's strategic acquisitions and partnerships are expected to further solidify its market leadership and expand its service offerings[5][8]. Financial Performance - Revenue from hair transplant services reached RMB1.33 billion, with a 16.3% increase in the number of patients receiving high-end services[22]. - Medical hair care services generated revenue of RMB445.8 million, representing a year-on-year growth of 14.8%, with a repurchase rate of 28.4%[22]. - Total revenue for 2024 was RMB1.80 billion, reflecting a 1.5% increase compared to the previous year[26]. - Gross profit amounted to RMB1.08 billion, with a gross profit margin of 60.1%, an increase of 4 percentage points[26]. - Net loss narrowed to RMB226.6 million, while EBITDA turned positive at RMB141.0 million[26]. - Total assets decreased to RMB1.73 billion from RMB2.44 billion in 2023[22]. - Total equity fell to RMB713.8 million, down from RMB942.3 million in 2023[22]. - Total liabilities decreased to RMB1.01 billion, compared to RMB1.50 billion in 2023[22]. - Average transaction value for hair transplant and medical hair care services increased to RMB22,306 and RMB5,773 respectively[25]. - For the year ended December 31, 2024, the Group's revenue was RMB1,804.5 million, an increase of 1.5% from RMB1,777.3 million in 2023[46]. - Gross profit for the same period was RMB1,084.2 million, up 8.7% from RMB997.2 million in 2023, with a gross profit margin of 60.1%, an increase of 4.0 percentage points from 56.1%[46]. - Revenue from hair transplant services amounted to RMB1,330.7 million, accounting for 73.7% of total revenue[51]. - The number of patients receiving hair transplant surgery was 59,655, with a significant increase of 16.3% in patients receiving the "Yongxiang" service compared to the previous year[51]. - The average spending per hair transplant patient was RMB22,306, slightly up from RMB22,174 in 2023[54]. - Revenue from medical hair care services amounted to RMB 445.8 million, accounting for 24.7% of total revenue for the year ended December 31, 2024[57]. - Average spending per medical hair care patient increased by 17.0% from RMB 4,934 to RMB 5,773 during the reporting period[59]. - The number of patients receiving medical hair care services was 77,222, a slight decrease from 78,687 in the previous year[59]. - The repurchase rate of medical hair care services increased to 28.4%, up from 23.4%[59]. Operational Efficiency - The company is focusing on strategic upgrades from "traffic-driven" to "value creation" in response to new industry trends[29]. - The company streamlined its clinic network by closing inefficient stores, reducing the total number of clinics to 74, and focusing resources on high-potential areas[30]. - As of 2024, the medical team consists of 1,401 members, including 242 doctors, enhancing the quality and professionalism of medical services[30]. - The "Hefan" system has been fully implemented, significantly improving per capita reception efficiency through intelligent management of reception, inventory, and finance[30]. - The company served over 120,000 patients during the reporting period, solidifying its position as the largest hair-related healthcare clinic chain in China[39]. - The company aims to deepen penetration into the women's market and strengthen chain operation capabilities to target high-quality growth[35]. - The focus on technological innovation and quality service aims to provide high-quality and convenient hair-related healthcare solutions[34]. - The company is exploring the operation model of functional small stores to verify the feasibility of a light-asset, high-turnover model[30]. - The company plans to create a "smart medical" benchmark to cover the entire life cycle of hair-related healthcare needs[35]. - The brand matrix includes "Yonghe Medical," "Yonghe Hair Transplant," "Svenson," "Yonghe Fa Zhi Chu," and "Harvard," covering various aspects of hair-related healthcare[38]. Strategic Initiatives - The company emphasizes long-termism to create value for shareholders and society amidst market challenges[36]. - The Group strategically closed and consolidated underperforming stores, enhancing operational efficiency and resource allocation[46]. - The total number of clinics and stores decreased from 88 in 2023 to 74 in 2024, reflecting a focus on core locations[44]. - The number of patients receiving services from business chiefs was 40,710, representing 68.2% of total patients[54]. - The number of patients receiving services from business deans was 15,411, accounting for 25.8% of total patients[54]. - The Group aims to strengthen brand influence through a strategic hierarchical service system in the hair transplant sector[52]. - The female business revenue saw a significant year-on-year increase due to the optimisation of the "Fa Zhi Chu" brand strategy and the establishment of female departments in core clinics[70]. - The group has built a professional medical team consisting of 1,401 members as of December 31, 2024[72]. - The group implemented a "fixed price" pricing strategy to respond effectively to market changes and fluctuations in consumer trends[64]. - The "Good Doctors are Around" initiative was launched to enhance access to high-standard medical services across different regions[64]. - The group upgraded its brand strategy to lead the industry into the hair transplant 3.0 era, focusing on professional training and assessment for physicians[70]. - Strategic cooperation agreements were signed with several pharmaceutical companies to enhance competitiveness in hair loss prevention and control, aiming for innovation in the hair healthcare industry[74]. Technological Advancements - The introduction of an AI hair health self-test tool significantly increased user conversion rates[77]. - The self-developed CRM system "Hefan" achieved full-link automation and intelligent management of leads, improving sales team follow-up efficiency and significantly increasing customer conversion rates[78]. - The Group's digital transformation was completed in 2024, focusing on "data-driven and intelligent collaboration" with the introduction of large language models (LLM)[83]. - The "Hefan" system fully digitizes processes such as patient files and outpatient records, achieving a "paperless" office environment and enhancing operational efficiency[84]. - The Group's marketing strategy integrated multiple channels and touchpoints, resulting in a higher conversion rate while controlling marketing costs[79]. - Collaboration with reputable medical schools and Grade 3A hospitals was strengthened to drive development in the hair healthcare sector through academic seminars and joint research projects[74]. - The Group's initiatives in AI technology led to breakthroughs in smart labelling and scalp image symptom recognition, significantly improving customer satisfaction[83]. - The dual wheel drive model of "group large and middle platforms + regional small and middle platforms" improved user lifecycle management and marketing ROI[77]. - The focus on digitalization and intelligence will drive operational efficiency and innovation, aiming to create an exceptional service experience for consumers[98]. Human Resources and Management - The Group's total bank borrowings decreased to RMB50.1 million in 2024 from RMB152.8 million in 2023[159]. - The gearing ratio improved to 7.0% as of December 31, 2024, down from 16.2% in 2023[174]. - The Group had trade and other payables of RMB149.4 million as of December 31, 2024, compared to RMB210.9 million in 2023[155]. - As of December 31, 2024, the Group had a total of 3,549 employees, including 1,401 in the professional medical team[179]. - Staff costs for the year ended December 31, 2024, were RMB 722.9 million, a decrease from RMB 835.1 million for the year ended December 31, 2023, representing a reduction of approximately 13.4%[179]. - The Group continues to provide competitive compensation packages and diverse training courses to its employees, adhering to industry practices and individual performance[180]. - The Group participates in various employee social security plans, including housing provident fund, pension, medical, maternity, work-related injury, and unemployment insurances, as required by PRC laws[180]. Leadership and Governance - Mr. Zhang Yu, the founder and CEO, has over 19 years of experience in the medical hair care service industry and has led the Group's strategic development since its inception in 2010[186]. - Under Mr. Zhang's leadership, the Group has expanded its business lines to include diagnosis and treatment of various hair-related diseases, hair transplant, and other related services[186]. - Mr. Zhang Hui, the senior vice president, has over 12 years of experience in the industry and has contributed to the Group's steady expansion through optimized supply chain management[192]. - Ms. Han Zhimei, with over 25 years of experience in finance, is responsible for the Group's financial management and has held various senior roles prior to her current position[190]. - The Group has established a management style reflective of the "Yonghe" brand values, achieving numerous prestigious accreditations and recognitions[186]. - Ms. Han has over 25 years of experience in accounting and corporate finance, previously serving as finance director at KR Space and general manager of finance center at CiMing Health Management Group[195]. - Mr. Geng has over 17 years of experience in investment and management, currently providing strategic development advice to the Group[200].

大家好欢迎参加中金公司永和医疗2024年度业绩说明会目前所有参会者均处于静音状态下面开始播报免责声明声明播报完毕后主持人可直接开始发言本次会议为中国国际金融股份有限公司中金公司闭门会议仅限受邀嘉宾参会未经中金公司和演讲嘉宾书面许可 任何机构和个人不得以任何形式将会议内容和相关信息对外公布转发转载传播复制编辑修改等如有上述违法行为中金公司保留追究相关方法律责任的权利This meeting is a closed-door meeting of China International Capital Corporation Limited, CICCand only invited guests are allowed to attend Without the written permission of CICC and the speaker, no organization or individual is allowed to punish, forward, reprint, disseminate, copy, edit or modify the meeting contents and rele ...